1. Home
  2. DTI vs IRD Comparison

DTI vs IRD Comparison

Compare DTI & IRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DTI
  • IRD
  • Stock Information
  • Founded
  • DTI 1984
  • IRD 2018
  • Country
  • DTI United States
  • IRD United States
  • Employees
  • DTI N/A
  • IRD N/A
  • Industry
  • DTI Metal Fabrications
  • IRD
  • Sector
  • DTI Industrials
  • IRD
  • Exchange
  • DTI Nasdaq
  • IRD NYSE
  • Market Cap
  • DTI 68.0M
  • IRD 60.9M
  • IPO Year
  • DTI N/A
  • IRD N/A
  • Fundamental
  • Price
  • DTI $2.62
  • IRD $0.99
  • Analyst Decision
  • DTI Strong Buy
  • IRD Strong Buy
  • Analyst Count
  • DTI 1
  • IRD 2
  • Target Price
  • DTI $5.50
  • IRD $7.00
  • AVG Volume (30 Days)
  • DTI 56.0K
  • IRD 151.1K
  • Earning Date
  • DTI 05-13-2025
  • IRD 05-15-2025
  • Dividend Yield
  • DTI N/A
  • IRD N/A
  • EPS Growth
  • DTI N/A
  • IRD N/A
  • EPS
  • DTI N/A
  • IRD N/A
  • Revenue
  • DTI $160,352,000.00
  • IRD $13,651,000.00
  • Revenue This Year
  • DTI $4.26
  • IRD $22.00
  • Revenue Next Year
  • DTI $6.26
  • IRD $100.89
  • P/E Ratio
  • DTI N/A
  • IRD N/A
  • Revenue Growth
  • DTI 8.19
  • IRD N/A
  • 52 Week Low
  • DTI $1.43
  • IRD $0.65
  • 52 Week High
  • DTI $6.36
  • IRD $2.18
  • Technical
  • Relative Strength Index (RSI)
  • DTI 57.72
  • IRD N/A
  • Support Level
  • DTI $2.34
  • IRD N/A
  • Resistance Level
  • DTI $2.79
  • IRD N/A
  • Average True Range (ATR)
  • DTI 0.23
  • IRD 0.00
  • MACD
  • DTI 0.02
  • IRD 0.00
  • Stochastic Oscillator
  • DTI 70.69
  • IRD 0.00

About DTI Drilling Tools International Corporation

Drilling Tools International Corp manufactures, rents, inspects, and refurbishes downhole drilling tools primarily to companies in the oil and natural gas industry for bottom hole assemblies used in onshore and offshore horizontal and directional drilling. The company's United States operations have locations in Texas, California, Louisiana, Oklahoma, Pennsylvania, North Dakota, New Mexico, Utah, and Wyoming. The company's single segment derives revenues from customers by providing oilfield equipment and services to operators in the oil and natural gas sectors.

About IRD OPUS GENETICS INC

Opus Genetics Inc is a clinical-stage ophthalmic biopharmaceutical company developing therapies to treat patients with inherited retinal diseases (IRDs) and therapies to treat patients with other retinal and refractive disorders. The pipeline includes adeno-associated virus (AAV)-based gene therapies that address mutations in genes that cause different forms of bestrophinopathy, Leber congenital amaurosis (LCA), and retinitis pigmentosa. The pipeline also includes Phentolamine Ophthalmic Solution 0.75%, a non-selective alpha-1 and alpha-2 adrenergic antagonist to reduce pupil size, and APX3330, a novel small-molecule inhibitor of Ref-1 to slow the progression of non-proliferative diabetic retinopathy.

Share on Social Networks: